Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q4 2020 · 10-K
Revenue—
Net Income-$4.41M-$4.41MN/M vs Q4 2019 EPS Diluted-$0.04-$0.04N/M vs Q4 2019 Operating Incomederived-$4,549,021N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Operating Cash Flowderived
ended Dec 31, 2020 · filed Mar 1, 2021 · 60 d after period end